Literature DB >> 16618343

Plasma total homocysteine levels are associated with advanced leukoaraiosis but not with asymptomatic microbleeds on T2*-weighted MRI in patients with stroke.

H Naka1, E Nomura, T Takahashi, S Wakabayashi, H Kajikawa, T Kohriyama, Y Mimori, M Matsumoto.   

Abstract

Both leukoaraiosis and asymptomatic microbleeds are associated with small-artery diseases. Although an association between hyperhomocysteinemia and leukoaraiosis has been reported, no studies have evaluated the association between total homocysteine (tHcy) level and presence of microbleeds in stroke patients. We evaluated the association between tHcy level and leukoaraiosis or microbleeds in stroke patients. In 102 patients with stroke (69.5 +/- 10.3 years old, 54 men and 48 women), microbleeds on T2*-weighted MR images were counted, leukoaraiosis on T2-weighted images was graded and fasting plasma tHcy concentrations were measured. Plasma tHcy level was significantly higher in patients with advanced leukoaraiosis than in those without advanced leukoaraiosis (13.9 +/- 4.6 micromol/l vs. 10.2 +/- 3.4 micromol/l, P < 0.0001). Plasma tHcy level was not significantly different in patients with microbleeds and those without microbleeds (11.3 +/- 4.1 micromol/l vs. 11.4 +/- 4.3 micromol/l, P = 0.9441). Elevated tHcy level is significantly and independently associated with advanced leukoaraiosis [odds ratio (OR), 1.330; 95% CI, 1.130-1.565] but not with the presence of microbleeds. Elevated tHcy level appears to be associated with ischemic small-artery disease rather than with bleeding-prone small-artery disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618343     DOI: 10.1111/j.1468-1331.2006.01205.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

Review 1.  Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review.

Authors:  Anna Poggesi; Marco Pasi; Francesca Pescini; Leonardo Pantoni; Domenico Inzitari
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  Evaluation of the MTHFR A1298C variant in leukoaraiosis.

Authors:  Zoltan Szolnoki; Istvan Szaniszlo; Marta Szekeres; Krisztina Hitri; Andras Kondacs; Yvette Mandi; Erika Nedo; Ferenc Somogyvari
Journal:  J Mol Neurosci       Date:  2011-08-16       Impact factor: 3.444

3.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

Review 4.  Endothelial Dysfunction and Hyperhomocysteinemia-Linked Cerebral Small Vessel Disease: Underlying Mechanisms and Treatment Timing.

Authors:  Shuang Li; Guangjian Li; Xia Luo; Yan Huang; Lan Wen; Jinglun Li
Journal:  Front Neurol       Date:  2021-11-24       Impact factor: 4.003

5.  Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis.

Authors:  Elena Tartara; Elisa Micalizzi; Sofia Scanziani; Elena Ballante; Matteo Paoletti; Carlo Andrea Galimberti
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

6.  Opening of the blood-brain barrier before cerebral pathology in mild hyperhomocysteinemia.

Authors:  Bryce C Rhodehouse; Jamie N Mayo; Richard S Beard; Cheng-Hung Chen; Shawn E Bearden
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

7.  H-Type Hypertension Is a Risk Factor for Cerebral Small-Vessel Disease.

Authors:  Tan Li; Xueyun Liu; Shanshan Diao; Yan Kong; Xiaoyu Duan; Si Yang; Sanjiao Liu; Qi Fang; Xiuying Cai
Journal:  Biomed Res Int       Date:  2020-02-07       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.